IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo
- PMID: 9126988
IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo
Abstract
Transcription factor interferon regulatory factor-1 (IRF-1) is implicated in regulating class I MHC expression in vitro. We investigated the in vivo relationship between IRF-1 and MHC expression in kidney and other nonlymphoid organs, assessing MHC expression in mice with disrupted IRF-1 genes (IRF-1 KO) compared with mice with intact IRF-1 genes (WT). In kidneys of IRF-1 KO mice, basal class I expression was decreased, particularly on arterial endothelium, but basal class II expression was unchanged. The induction of both class I and class II expression by injected rIFN-gamma was reduced in IRF-1 KOs, compared with WT mice. Similarly, stimuli that induce endogenous IFN-gamma production (LPS or oxazolone) massively increased MHC expression in kidneys of WT mice, with little increase in IRF-1 KO mice. Impaired class II induction by rIFN-gamma in IRF-1 KO mice probably reflects the role of IRF-1 in regulating class II transactivator (CIITA) expression: rIFN-gamma induced CIITA mRNA less in kidneys of IRF-1 KO mice than in WT mice. In organs of WT mice, IRF-1 mRNA was expressed in the basal state, and rIFN-gamma treatment increased IRF-1 mRNA before the induction of class I or CIITA mRNA. Treatment of WT mice with cycloheximide plus rIFN-gamma superinduced IRF-1 mRNA expression, but partially inhibited CIITA mRNA expression, indicating that IRF-1 mRNA induction is not dependent on new protein synthesis, unlike CIITA. Thus, in vivo, IRF-1 plays a major role in basal and induced class I expression and in induction of class II by IFN-gamma, probably via CIITA induction.
Similar articles
-
Impaired class II transactivator expression in mice lacking interferon regulatory factor-2.Oncogene. 2001 Jul 12;20(31):4219-27. doi: 10.1038/sj.onc.1204556. Oncogene. 2001. PMID: 11464288
-
IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.J Immunol. 1999 Jan 15;162(2):886-96. J Immunol. 1999. PMID: 9916712
-
IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.J Immunol. 1999 Apr 15;162(8):4731-9. J Immunol. 1999. PMID: 10202014
-
Regulation of class II MHC gene expression by interferons: insights into the mechanism of action of interferon (review).Anticancer Res. 1988 Nov-Dec;8(6):1153-61. Anticancer Res. 1988. PMID: 2464333 Review.
-
Regulation of complement gene expression.Biochem Soc Symp. 1986;51:37-46. Biochem Soc Symp. 1986. PMID: 3101700 Review.
Cited by
-
Oncolytic Virotherapy: The Cancer Cell Side.Cancers (Basel). 2021 Feb 24;13(5):939. doi: 10.3390/cancers13050939. Cancers (Basel). 2021. PMID: 33668131 Free PMC article. Review.
-
Frequent Loss of IRF2 in Cancers Leads to Immune Evasion through Decreased MHC Class I Antigen Presentation and Increased PD-L1 Expression.J Immunol. 2019 Oct 1;203(7):1999-2010. doi: 10.4049/jimmunol.1900475. Epub 2019 Aug 30. J Immunol. 2019. PMID: 31471524 Free PMC article.
-
NLRC5/CITA: A Key Player in Cancer Immune Surveillance.Trends Cancer. 2017 Jan;3(1):28-38. doi: 10.1016/j.trecan.2016.12.003. Epub 2017 Jan 10. Trends Cancer. 2017. PMID: 28718425 Free PMC article. Review.
-
Recent Advances in Mouse Models of Sjögren's Syndrome.Front Immunol. 2020 Jun 30;11:1158. doi: 10.3389/fimmu.2020.01158. eCollection 2020. Front Immunol. 2020. PMID: 32695097 Free PMC article. Review.
-
MDM2 inhibitors in cancer immunotherapy: Current status and perspective.Genes Dis. 2024 Mar 28;11(6):101279. doi: 10.1016/j.gendis.2024.101279. eCollection 2024 Nov. Genes Dis. 2024. PMID: 39263534 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Molecular Biology Databases
Research Materials